Mostrar el registro sencillo del ítem

Frecuencia de trombofilias en una población de pacientes con episodios trombóticos en un hospital universitario de III nivel

dc.contributor.advisorFeliciano Alfonso, John Edwin
dc.contributor.authorCancelado Jácome, Sergio Andrés
dc.contributor.authorChinchía Arias, Isabel Matilde
dc.contributor.authorSalazar Muñoz, Johana Milena
dc.contributor.authorCalderón Vargas, Carlos Mauricio
dc.date.accessioned2012-07-25T15:15:05Z
dc.date.available2012-07-25T15:15:05Z
dc.date.created2012-07-25
dc.date.issued2011
dc.identifier.citationDahlbäch B, Carlson M, Svenson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated Protein C. Proc Natl Acad Sci 1993; 90: 1004.
dc.identifier.citationGuidelines on the investigation and management of thrombophilia. J Clin Pathol 1990; 49: 703.
dc.identifier.citationGRIFFIN V, SELIGSOH U, RAPPORT S. Coagulation abnormalities in thrombosis. American Society Hematology. Educational Session. Bocklet, Seattle, Washington 1995; 51‐8.
dc.identifier.citationCONRAD F. Thrombophilia: diagnosis and management. En: Poller L, Thomas JM (eds): Thrombosis and its Management. London: Churchill‐Livingstone Inc 1993; 113‐ 25.
dc.identifier.citation. Bauer K, Goodnight S, Ridkes P. Hypercoagulable States‐Translation of Risk Factors to Clinical Practice. The American Society of Hematology Education Program Book. Janine Editor 1998; 255‐73.
dc.identifier.citationArnaud E, Reny J, Emmerich J, Aiach M. Thrombose veineusse et anomalies genétiques de l’hémostase. Sang Thrombose et Vaissaux 2000; 7: 426‐32.
dc.identifier.citationHeijboer H, Brandjes D, Büller H, Sturka A, Ten Cate J. Deficiencies of coagulation‐ inhibitingand fibrinolytic proteins in outpatients with deep venous thrombosis. N Engl J Med 1990; 323: 1512‐6.
dc.identifier.citationHach‐Wunderle V, Scharrer I. Prevalence of hereditary deficiency of antithrombin III, Protein C en Protein S. Dtsch Med Wochenschr 1993; 118: 187‐90.  
dc.identifier.citationDahlbäch B. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg (506) to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis. Thromb Haemost 1995; 74: 139‐48.
dc.identifier.citationBertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and Factor V  as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449‐53.
dc.identifier.citationMercier E, Queré I, Gris J‐C. Variant 20210 A dugène de la Prothrombine et Thrombose. STV 2001; 4: 13‐23.
dc.identifier.citationGrinsberg JS. Management of venous thromboembolism. N Engl J Med 1996; 335: 1816‐28.  
dc.identifier.citationDerksen Rh, De Groot Pg, Kater L, Nieuwenhuis Hk. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993; 52: 689‐92.
dc.identifier.citationKhamashta Ma, Cuadrado Mj, Mujic F, Taub Na, Hunt Bj, Hughes Gr. The management of thrombosis in the antiphospholipid antibody syndrome. N Eng J Med 1995; 332: 993‐7
dc.identifier.citationTorres, J. Inherited Thrombophilia is Associated With Deep Vein Thrombosis in a Colombian Population. American Journal of Hematology 81:933–937 (2006).
dc.identifier.citationAlfirevic, Z, Alfirevic, V. Hypercoagulable state, pathophysiology, classification and epidemiology. Clin Chem Lab Med 2010;48(Suppl 1):S15–S26
dc.identifier.citation. Stegnar, M. Thrombophilia screening – at the right time, for the right patient, with a good reason. Clin Chem Lab Med 2010;48(Suppl 1):S105–S113  2010
dc.identifier.citationAlfirevic, Z, Alfirevic, V. Hypercoagulable state, pathophysiology, classification and epidemiology. Clin Chem Lab Med 2010;48(Suppl 1):S15–S26
dc.identifier.citation. Olson ST, Björk I. Regulation of thrombin activity by antithrombin and heparin. Semin Thromb Hemost 1994;20(4):373e409.
dc.identifier.citationAnderson J, Witz J. Hypercoagulable States. Clin Chest Med 31 (2010) 659–673
dc.identifier.citationHirsh J, Bauer KA, Donati MB, et al. Parenteral anticoagulants: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133:141S.  
dc.identifier.citationMartinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92:2353. 
dc.identifier.citationMosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109:3161.
dc.identifier.citationTait RC, Walker ID, Reitsma PH, et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73:87.   
dc.identifier.citationBruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case‐control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ 1998; 316:589
dc.identifier.citationNazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin‐induced skin necrosis. J Am Acad Dermatol 2009; 61:325.
dc.identifier.citationRezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein  S and the protein S‐C4b binding protein complex. Blood 2004; 103:1192
dc.identifier.citationRezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein  S and the protein S‐C4b binding protein complex. Blood 2004; 103:1192.  
dc.identifier.citationMustafa S, Mannhalter C, Rintelen C, et al. Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V . Blood Coagul Fibrinolysis 1998; 9:85.
dc.identifier.citationMateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism‐‐results of the Spanish Multicentric Study on Thrombophilia (EMET‐Study). Thromb Haemost 1997; 77:444.
dc.identifier.citationCastoldi E, Brugge JM, Nicolaes GA, et al. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations. Blood 2004; 103:4173
dc.identifier.citationCastoldi E, Rosing J. APC resistance: biological basis and acquired influences. J Thromb Haemost 2010; 8:445.
dc.identifier.citationPoort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'‐untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698.
dc.identifier.citationRosendaal FR, Doggen CJ, Zivelin A, et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998; 79:706
dc.identifier.citationO'Donnell J, Tuddenham EG, Manning R, et al. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77:825.
dc.identifier.citationViel KR, Machiah DK, Warren DM, et al. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood 2007; 109:3713.
dc.identifier.citationLodi S, Isa L, Pollini E, et al. Defective intrinsic fibrinolytic activity in a patient with severe factor XII‐deficiency and myocardial infarction. Scand J Haematol 1984; 33:80.
dc.identifier.citationGoldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol 2010; 56:1
dc.identifier.citationAnderson J, Witz J. Hypercoagulable States. Clin Chest Med 31 (2010) 659–673
dc.identifier.citationMiyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295.
dc.identifier.citationGeerts, W. Pineo,G. Prevention of Venous Thromboembolism. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
dc.identifier.citationKujovich JL. Hormones and pregnancy: thromboembolic risks for women. Br J Haematol 2004; 126:443.
dc.identifier.citationSpencer FA, Emery C, Lessard D, et al. The Worcester Venous Thromboembolism study: a population‐based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21:722.
dc.identifier.citationPomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 2008; 83:97
dc.identifier.citationMinisterio de Salud .Resolución No. 008430 de 1993.
dc.identifier.urihttp://hdl.handle.net/10818/3168
dc.description51 Páginas.
dc.description.abstractLas trombofilias se definen como tendencia a las trombosis, con variedad de manifestaciones clínicas. Se determinó la frecuencia de trombofilias en una población de pacientes con episodios trombóticos de la Consulta Externa de Hematología en un Hospital de III Nivel de Cundinamarca. Se incluyeron 94 pacientes, 70.2% presentó un evento trombótico, 16% presentó 2 eventos y 13.9% presentó 3 o más; en 47.9% pacientes se identifico alguna trombofilia. Las trombofilias encontradas fueron: Síndrome Antifosfolípidos, Déficit de Proteína S, Déficit de Proteína C, Déficit de Antitrombina III, Resistencia a la Proteína C – Factor V de Leiden, Hiper factor VIII, Mutación del Gen de la Protrombina 20210A. La mayoría de pacientes presentó eventos trombóticos venosos. El tratamiento más frecuente fue la anticoagulación.es_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectTrombofilia-Investigacioneses_CO
dc.titleFrecuencia de trombofilias en una población de pacientes con episodios trombóticos en un hospital universitario de III niveles_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Interna
dc.publisher.departmentFacultad de Medicina
dc.identifier.local152679
dc.identifier.localTE00280
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialista en Medicina Interna


Ficheros en el ítem

Thumbnail
Nombre:
Sergio Andrés Cancelado Jácome.pdf
Tamaño:
1.056Mb
Formato:
PDF
Descripción:
Ver documento en PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem